Form D · Biotechnology
Spear Bio Inc.
Woburn, MA · CIK 0001852708
Offering snapshot reported Aug 5, 2024 · SEC filing
- Reported sold
- $45M Offering amount: $45M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 23, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 5, 2024 | Initial | $44,999,997 | No comparison | 8 | SEC filing |
| Oct 18, 2022 | Initial | $2,391,188 | No comparison | 5 | SEC filing |
| Oct 14, 2021 | Initial | $1,571,429 | No comparison | 3 | SEC filing |
| Mar 26, 2021 | Initial | $1,100,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-520615
Source: Form D, filed Aug 5, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vikram Bajaj | Director |
| Wen Chan | Director |
| Jerome Clavel | Director, Executive |
| Michael Natan | Director, Executive |
| David Singer | Director |
| John Wu | Executive |
| Feng Xuan | Director, Executive |
| Peng Yin | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Tradecenter Dr., Suite 510
Woburn, MA, 01801
Woburn, MA, 01801